The production of emerging virus-based gene therapies, cell therapies, vaccines, and cancer treatments requires new types of facilities for manufacturers to build. GE Healthcare promises to help make it easy by unveiling their KUBio “factory-in-a-box” offering.
The company in particular hopes to fill a need for facilities that can produce vaccines quickly and as the need arises. “The investment needed to build these facilities has been high, and the lack of flexibility has hindered the capability to invest,” in a statements aid Daria Donati, director of business development and innovation for the BioProcess business of GE Healthcare Life Sciences. “We believe that bringing to the market a solution that mitigates some of the challenges in flexibility and timing can help the manufacture of vaccines.”
More at GE Healthcare…